CoChat

In Vitro Evolution of Itraconazole Resistance in Aspergillus fumigatus Involves Multiple Mechanisms of Resistance

Open access
da Silva Ferreira, Márcia Eliana, Capellaro, José Luiz, dos Reis Marques, Everaldo, Malavazi, Iran, Perlin, David, Park, Steven, Anderson, James B., Colombo, Arnaldo L., Arthington-Skaggs, Beth A., Goldman, Maria Helena S., Goldman, Gustavo H. · 2004 · Antimicrobial Agents and Chemotherapy
Cited by 147

The DOI matches its Crossref record; 15 of the 15 references it cites were found in a registry or an index.

Abstract

We investigated the evolution of resistance to the antifungal drug itraconazole in replicate populations of Aspergillus fumigatus that were founded from a strain with a genotype of sensitivity to a single drug and then propagated under uniform conditions. For each population, conidia were serially transferred 10 times to agar medium either with or without itraconazole. After 10 transfers in medium supplemented with itraconazole, 10 itraconazole-resistant mutant strains were isolated from two populations. These mutant strains had different growth rates and different levels of itraconazole resistance. Analysis of the ergosterol contents of these mutants showed that they accumulate ergosterol when they are grown in the presence of itraconazole. The replacement of the CYP51A gene of the wild-type strain changed the susceptibility pattern of this strain to one of itraconazole resistance only when CYP51A genes with N22D and M220I mutations were used as selectable marker genes. Real-time quantitative reverse transcription-PCR was used to assess the levels of expression of the Afumdr1 , Afumdr2 , Afumdr3 , Afumdr4 , AtrF transporter, CYP51A , and CYP51B genes in these mutant strains. Most mutants showed either constitutive high-level expression or induction upon exposure of Afumdr3 , Afumdr4 , and AtrF to itraconazole. Our results suggest that overexpression of drug efflux pumps and/or selection of drug target site mutations are at least partially responsible for itraconazole resistance and could be considered mechanisms for the emergence of clinical resistance to this drug.

Overview

The claims and statistics of this paper haven’t been checked yet.

Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.

A few free checks a day · papers already verified open instantly · results are public

Integrity signals

Registry

Crossref · 10.1128/aac.48.11.4405-4413.2004

Cites

15 of 15 references verified0 citation errors · 0 not checkable

Statistics

Verification

Claims the paper makes

The claims and statistics of this paper haven’t been checked yet.

Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.

A few free checks a day · papers already verified open instantly · results are public

Self-check

Percentages, sums and reported differences re-computed from the paper’s own numbers.

The self-check needs the paper’s full text.

Citations

Cites

Show all 15 references

Cited by

See all 147

Metadata

Authors
da Silva Ferreira, M. E., Capellaro, J. L., dos Reis Marques, E., Malavazi, I., Perlin, D., Park, S., Anderson, J. B., Colombo, A. L., Arthington-Skaggs, B. A., Goldman, M. H. S., & Goldman, G. H.
Venue
Antimicrobial Agents and Chemotherapy
Published
2004-11
Volume
48
Issue
11
Pages
4405-4413
ISSN
  • 0066-4804 (ISSN-L)
  • 1098-6596
OpenAlex
W2101019830
Cited by
147
References
15
FWCI
1.91
Type
journal article
Language
en
Open access
bronze

About these checks

Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.

Statistics and arithmetic are recomputed, not judged.

Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.

What counts as a claim ›How we measure confidence ›How we check this ›

Are you an author, or do you see a problem with this page? Request a review

How to cite

Cite CoChat for the checks on this page, and the paper for its own findings.

This page
CoChat. (2026). Citation check: In Vitro Evolution of Itraconazole Resistance in Aspergillus fumigatus Involves Multiple Mechanisms of Resistance. https://app.cochat.ai/papers/10.1128/aac.48.11.4405-4413.2004
The paper
da Silva Ferreira, M. E., Capellaro, J. L., dos Reis Marques, E., Malavazi, I., Perlin, D., Park, S., Anderson, J. B., Colombo, A. L., Arthington-Skaggs, B. A., Goldman, M. H. S., & Goldman, G. H. (2004). In Vitro Evolution of Itraconazole Resistance in Aspergillus fumigatus Involves Multiple Mechanisms of Resistance. Antimicrobial Agents and Chemotherapy. https://doi.org/10.1128/aac.48.11.4405-4413.2004

Data sources

Bibliographic data: Semantic Scholar, OpenAlex, Crossref.

Contains information from the Semantic Scholar Academic Graph Datasets, made available under the ODC Attribution License (ODC-BY 1.0).

Semantic Scholar’s data is described in: Kinney, R., et al. (2023). The Semantic Scholar Open Data Platform. arXiv:2301.10140.